Tuesday, March 12, 2013 5:03:16 PM
As it happens, I have never imagined that they'd solve all of the problems they have... by this year. That they're still in full denial about the problems they do have... makes that a far more certain bet. I doubt they're on the cusp of resolving issues that they refuse to admit are problems.
A year ago... they said they were "ramping up production" ? Now, a year later... we're trying to reinvent that moment while pretending it hasn't happened before ?
People have been working on trying to figure out the problems which, when solved, will allow us to manufacture artificial silk... for a long time. I'm not the one who is claiming that there's been any major breakthroughs that enables commercial success, now ?
Those who ARE making those claims... bear the burden of proof. But, when you ask KBLB about proofs of simple things like... basic awareness of the market, or a plan that might enable establishing a based of production... what do you get ? Nothing but claims that others will gladly figure all that out for them, and do it for them... so KBLB doesn't need to know what they're doing ?
Thus far, KBLB has failed in providing any of that basic sort of proof that they're aware enough of their markets that they know what they're doing... and, worse, they've provided proofs that they're not being honest in addressing the nature of the challenges in the science, or in the competition.
FWIW... I'm the one pointing out... that they're not there yet... while not being deluded into thinking they are, and not being suckered in to "your imagination of how long such things should take."
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM